Figure 3.
Kaplan-Meier product limit estimate of disease-free survival (DFS) from the time of complete response (CR).Reprinted with permission from
Sanz M, Martin G, Rayon C, et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia.
Blood.
1999
;94
:3015
–3021.
